The Efficacy of Silymarin and Vitamin E in Non-Alcoholic Fatty Liver Disease: A Clinical Trial

Abstract Objective: Nowadays, lifestyle modification is the best treatment recommended to patients with the nonalcoholic fatty liver disease (NAFLD). The therapeutic effects of vitamin E and silybin on liver functions were documented. The present study was conducted to examine the effect of silymari...

Full description

Bibliographic Details
Main Authors: Mohsen Akhondi-Meybodi, Mahmoud Baghbanian, Abolfazl Namazi
Format: Article
Language:English
Published: Shahid Sadoughi University of Medical Sciences 2020-06-01
Series:Iranian Journal of Diabetes and Obesity
Subjects:
Online Access:http://ijdo.ssu.ac.ir/article-1-559-en.html
id doaj-ce54087cb9534ae9a2883c131847a591
record_format Article
spelling doaj-ce54087cb9534ae9a2883c131847a5912020-11-25T03:41:10ZengShahid Sadoughi University of Medical SciencesIranian Journal of Diabetes and Obesity 2008-67922345-22502020-06-011228489The Efficacy of Silymarin and Vitamin E in Non-Alcoholic Fatty Liver Disease: A Clinical TrialMohsen Akhondi-Meybodi0Mahmoud Baghbanian1Abolfazl Namazi2 Associate Professor of Medicine, Shahid Sadoughi University of Medical Science, Yazd, Iran Associate Professor of Medicine, Shahid Sadoughi University of Medical Science, Yazd, Iran Internist of Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Science, Yazd, Iran Abstract Objective: Nowadays, lifestyle modification is the best treatment recommended to patients with the nonalcoholic fatty liver disease (NAFLD). The therapeutic effects of vitamin E and silybin on liver functions were documented. The present study was conducted to examine the effect of silymarin and vitamin E on patients with NAFLD. Materials and Methods: From September 2014 to March 2015, clinical trial was conducted on 92 patients with NAFLD at 2 Shahid Sadoughi university clinical research centers. Sampling was based on convenient method. There were no randomization or blinding in this study, but two types of treatments were compared. The patients were divided in two groups of daily intake of vitamin E (400 IU) and Silymarin 280 mg for four months. Alanine aminotransferase (ALT) and liver ultrasonography were done at baseline and after four months. Results: Eighty patients completed the course of treatment successfully .After 4 months, both groups had experienced a significant reduction in their serum ALT levels. The mean change in the ALT level from the baseline was -31.6 U/L in the silymarin group vs. -15.1 U/L in the vitamin E group (P-value= 0.07). Treatment with silymarin was more effective than vitamin E (P-value< 0.0001). The mean ALT level changed to normal was 55.0% (22 of 40 patients )in the silymarin group, while it was 45.0% (18 of 40 cases) in the vitamin E group (P-value= 0.04). Conclusion: The treatment of NAFLD with silymarin appears to be significantly effective in biochemical improvement whereas treatment with vitamin E improves ultrasonographic parameters.http://ijdo.ssu.ac.ir/article-1-559-en.htmlnonalcoholic fatty liver diseasesilymarinvitamin eclinical trial
collection DOAJ
language English
format Article
sources DOAJ
author Mohsen Akhondi-Meybodi
Mahmoud Baghbanian
Abolfazl Namazi
spellingShingle Mohsen Akhondi-Meybodi
Mahmoud Baghbanian
Abolfazl Namazi
The Efficacy of Silymarin and Vitamin E in Non-Alcoholic Fatty Liver Disease: A Clinical Trial
Iranian Journal of Diabetes and Obesity
nonalcoholic fatty liver disease
silymarin
vitamin e
clinical trial
author_facet Mohsen Akhondi-Meybodi
Mahmoud Baghbanian
Abolfazl Namazi
author_sort Mohsen Akhondi-Meybodi
title The Efficacy of Silymarin and Vitamin E in Non-Alcoholic Fatty Liver Disease: A Clinical Trial
title_short The Efficacy of Silymarin and Vitamin E in Non-Alcoholic Fatty Liver Disease: A Clinical Trial
title_full The Efficacy of Silymarin and Vitamin E in Non-Alcoholic Fatty Liver Disease: A Clinical Trial
title_fullStr The Efficacy of Silymarin and Vitamin E in Non-Alcoholic Fatty Liver Disease: A Clinical Trial
title_full_unstemmed The Efficacy of Silymarin and Vitamin E in Non-Alcoholic Fatty Liver Disease: A Clinical Trial
title_sort efficacy of silymarin and vitamin e in non-alcoholic fatty liver disease: a clinical trial
publisher Shahid Sadoughi University of Medical Sciences
series Iranian Journal of Diabetes and Obesity
issn 2008-6792
2345-2250
publishDate 2020-06-01
description Abstract Objective: Nowadays, lifestyle modification is the best treatment recommended to patients with the nonalcoholic fatty liver disease (NAFLD). The therapeutic effects of vitamin E and silybin on liver functions were documented. The present study was conducted to examine the effect of silymarin and vitamin E on patients with NAFLD. Materials and Methods: From September 2014 to March 2015, clinical trial was conducted on 92 patients with NAFLD at 2 Shahid Sadoughi university clinical research centers. Sampling was based on convenient method. There were no randomization or blinding in this study, but two types of treatments were compared. The patients were divided in two groups of daily intake of vitamin E (400 IU) and Silymarin 280 mg for four months. Alanine aminotransferase (ALT) and liver ultrasonography were done at baseline and after four months. Results: Eighty patients completed the course of treatment successfully .After 4 months, both groups had experienced a significant reduction in their serum ALT levels. The mean change in the ALT level from the baseline was -31.6 U/L in the silymarin group vs. -15.1 U/L in the vitamin E group (P-value= 0.07). Treatment with silymarin was more effective than vitamin E (P-value< 0.0001). The mean ALT level changed to normal was 55.0% (22 of 40 patients )in the silymarin group, while it was 45.0% (18 of 40 cases) in the vitamin E group (P-value= 0.04). Conclusion: The treatment of NAFLD with silymarin appears to be significantly effective in biochemical improvement whereas treatment with vitamin E improves ultrasonographic parameters.
topic nonalcoholic fatty liver disease
silymarin
vitamin e
clinical trial
url http://ijdo.ssu.ac.ir/article-1-559-en.html
work_keys_str_mv AT mohsenakhondimeybodi theefficacyofsilymarinandvitamineinnonalcoholicfattyliverdiseaseaclinicaltrial
AT mahmoudbaghbanian theefficacyofsilymarinandvitamineinnonalcoholicfattyliverdiseaseaclinicaltrial
AT abolfazlnamazi theefficacyofsilymarinandvitamineinnonalcoholicfattyliverdiseaseaclinicaltrial
AT mohsenakhondimeybodi efficacyofsilymarinandvitamineinnonalcoholicfattyliverdiseaseaclinicaltrial
AT mahmoudbaghbanian efficacyofsilymarinandvitamineinnonalcoholicfattyliverdiseaseaclinicaltrial
AT abolfazlnamazi efficacyofsilymarinandvitamineinnonalcoholicfattyliverdiseaseaclinicaltrial
_version_ 1724531185407754240